Earkart — 360° view

Earkart, a company in the Medical Equipment & Supplies industry, reported revenue of ₹31 crore and net profit of ₹1.17 crore for the September 2026 quarter.

Earkart (BSE: EARKART) closed at ₹102.00 on 20 Nov 2026, down 50.2% over the past year. Its market capitalisation is ₹140 crore and it trades at 36.9 times earnings.

Share price
₹102.00 (20 Nov 2026)
Market cap
₹140 Cr (20 Nov 2026)
P/E
36.92 (20 Nov 2026)
Revenue
₹31 Cr (September 2026 quarter)
Net profit
₹1 Cr (September 2026 quarter)
ROCE
17.5% (FY26)
ROE
11.7% (FY26)
Book value
₹47.6 (FY26)
Dividend yield
0.00% (FY26)
52-week high / low
₹195.00 / ₹102.00 (20 Nov 2026)
1-year return
-50.2% (to 20 Nov 2026)
Sector
Healthcare
Industry
Medical Equipment & Supplies
Symbol
BSE: EARKART

Earkart an Indian tech-driven hearing healthcare company dedicated to making advanced audiology services and hearing aids more accessible, affordable, and transparent. Listed on the BSE SME platform, it operates across India and neighboring countries, specializing in both manufacturing and distributing modern digital hearing solutions

Descriptive research only, not investment advice. Evenstocks is not a SEBI-registered investment adviser.